Cargando…
Prolonged Activation of Virus-Specific CD8(+)T Cells after Acute B19 Infection
BACKGROUND: Human parvovirus B19 (B19) is a ubiquitous and clinically significant pathogen, causing erythema infectiosum, arthropathy, transient aplastic crisis, and intrauterine fetal death. The phenotype of CD8(+) T cells in acute B19 infection has not been studied previously. METHODS AND FINDINGS...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1274280/ https://www.ncbi.nlm.nih.gov/pubmed/16253012 http://dx.doi.org/10.1371/journal.pmed.0020343 |
_version_ | 1782125980105572352 |
---|---|
author | Isa, Adiba Kasprowicz, Victoria Norbeck, Oscar Loughry, Andrew Jeffery, Katie Broliden, Kristina Klenerman, Paul Tolfvenstam, Thomas Bowness, Paul |
author_facet | Isa, Adiba Kasprowicz, Victoria Norbeck, Oscar Loughry, Andrew Jeffery, Katie Broliden, Kristina Klenerman, Paul Tolfvenstam, Thomas Bowness, Paul |
author_sort | Isa, Adiba |
collection | PubMed |
description | BACKGROUND: Human parvovirus B19 (B19) is a ubiquitous and clinically significant pathogen, causing erythema infectiosum, arthropathy, transient aplastic crisis, and intrauterine fetal death. The phenotype of CD8(+) T cells in acute B19 infection has not been studied previously. METHODS AND FINDINGS: The number and phenotype of B19-specific CD8(+) T cell responses during and after acute adult infection was studied using HLA–peptide multimeric complexes. Surprisingly, these responses increased in magnitude over the first year post-infection despite resolution of clinical symptoms and control of viraemia, with T cell populations specific for individual epitopes comprising up to 4% of CD8(+) T cells. B19-specific T cells developed and maintained an activated CD38(+) phenotype, with strong expression of perforin and CD57 and downregulation of CD28 and CD27. These cells possessed strong effector function and intact proliferative capacity. Individuals tested many years after infection exhibited lower frequencies of B19-specific cytotoxic T lymphocytes, typically 0.05%–0.5% of CD8(+) T cells, which were perforin, CD38, and CCR7 low. CONCLUSION: This is the first example to our knowledge of an “acute” human viral infection inducing a persistent activated CD8(+) T cell response. The likely explanation—analogous to that for cytomegalovirus infection—is that this persistent response is due to low-level antigen exposure. CD8(+) T cells may contribute to the long-term control of this significant pathogen and should be considered during vaccine development. |
format | Text |
id | pubmed-1274280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-12742802005-11-01 Prolonged Activation of Virus-Specific CD8(+)T Cells after Acute B19 Infection Isa, Adiba Kasprowicz, Victoria Norbeck, Oscar Loughry, Andrew Jeffery, Katie Broliden, Kristina Klenerman, Paul Tolfvenstam, Thomas Bowness, Paul PLoS Med Research Article BACKGROUND: Human parvovirus B19 (B19) is a ubiquitous and clinically significant pathogen, causing erythema infectiosum, arthropathy, transient aplastic crisis, and intrauterine fetal death. The phenotype of CD8(+) T cells in acute B19 infection has not been studied previously. METHODS AND FINDINGS: The number and phenotype of B19-specific CD8(+) T cell responses during and after acute adult infection was studied using HLA–peptide multimeric complexes. Surprisingly, these responses increased in magnitude over the first year post-infection despite resolution of clinical symptoms and control of viraemia, with T cell populations specific for individual epitopes comprising up to 4% of CD8(+) T cells. B19-specific T cells developed and maintained an activated CD38(+) phenotype, with strong expression of perforin and CD57 and downregulation of CD28 and CD27. These cells possessed strong effector function and intact proliferative capacity. Individuals tested many years after infection exhibited lower frequencies of B19-specific cytotoxic T lymphocytes, typically 0.05%–0.5% of CD8(+) T cells, which were perforin, CD38, and CCR7 low. CONCLUSION: This is the first example to our knowledge of an “acute” human viral infection inducing a persistent activated CD8(+) T cell response. The likely explanation—analogous to that for cytomegalovirus infection—is that this persistent response is due to low-level antigen exposure. CD8(+) T cells may contribute to the long-term control of this significant pathogen and should be considered during vaccine development. Public Library of Science 2005-12 2005-11-01 /pmc/articles/PMC1274280/ /pubmed/16253012 http://dx.doi.org/10.1371/journal.pmed.0020343 Text en Copyright: © 2005 Isa et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Isa, Adiba Kasprowicz, Victoria Norbeck, Oscar Loughry, Andrew Jeffery, Katie Broliden, Kristina Klenerman, Paul Tolfvenstam, Thomas Bowness, Paul Prolonged Activation of Virus-Specific CD8(+)T Cells after Acute B19 Infection |
title | Prolonged Activation of Virus-Specific CD8(+)T Cells after Acute B19 Infection |
title_full | Prolonged Activation of Virus-Specific CD8(+)T Cells after Acute B19 Infection |
title_fullStr | Prolonged Activation of Virus-Specific CD8(+)T Cells after Acute B19 Infection |
title_full_unstemmed | Prolonged Activation of Virus-Specific CD8(+)T Cells after Acute B19 Infection |
title_short | Prolonged Activation of Virus-Specific CD8(+)T Cells after Acute B19 Infection |
title_sort | prolonged activation of virus-specific cd8(+)t cells after acute b19 infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1274280/ https://www.ncbi.nlm.nih.gov/pubmed/16253012 http://dx.doi.org/10.1371/journal.pmed.0020343 |
work_keys_str_mv | AT isaadiba prolongedactivationofvirusspecificcd8tcellsafteracuteb19infection AT kasprowiczvictoria prolongedactivationofvirusspecificcd8tcellsafteracuteb19infection AT norbeckoscar prolongedactivationofvirusspecificcd8tcellsafteracuteb19infection AT loughryandrew prolongedactivationofvirusspecificcd8tcellsafteracuteb19infection AT jefferykatie prolongedactivationofvirusspecificcd8tcellsafteracuteb19infection AT brolidenkristina prolongedactivationofvirusspecificcd8tcellsafteracuteb19infection AT klenermanpaul prolongedactivationofvirusspecificcd8tcellsafteracuteb19infection AT tolfvenstamthomas prolongedactivationofvirusspecificcd8tcellsafteracuteb19infection AT bownesspaul prolongedactivationofvirusspecificcd8tcellsafteracuteb19infection |